# Florence Dalenc

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/florence-dalenc/

## Facts

| Field | Value |
| --- | --- |
| Citations | 16,206 |
| Field | Advanced Breast Cancer Therapies |
| h-index | 55 |
| i10-index | 174 |
| Last Known Institution | Inserm |
| OpenAlex ID | https://openalex.org/A5058791215 |
| ORCID iD | https://orcid.org/0000-0002-9854-4182 |
| Works | 564 |

## Researcher papers

- [Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer](https://scholariq.org/papers/sacituzumab-govitecan-in-metastatic-triple-negative-breast-cancer/)
- [Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD Trial](https://scholariq.org/papers/elacestrant-oral-selective-estrogen-receptor-degrader-versus-standard-endocrine/)
- [Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer](https://scholariq.org/papers/biomarker-analyses-in-the-phase-iii-ascent-study-of-sacituzumab-govitecan-versus/)
- [Letrozole and palbociclib versus chemotherapy as neoadjuvant therapy of high-risk luminal breast cancer](https://scholariq.org/papers/letrozole-and-palbociclib-versus-chemotherapy-as-neoadjuvant-therapy-of-high/)

## Researcher topics

- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Estrogen and related hormone effects](https://scholariq.org/topics/estrogen-and-related-hormone-effects/)

## Researcher university

- [Inserm](https://scholariq.org/institutions/inserm/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.